摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-amino-4-piperidino-benzophenone | 56106-79-7

中文名称
——
中文别名
——
英文名称
3-amino-4-piperidino-benzophenone
英文别名
(3-amino-4-piperidin-1-ylphenyl)-phenylmethanone
3-amino-4-piperidino-benzophenone化学式
CAS
56106-79-7
化学式
C18H20N2O
mdl
——
分子量
280.37
InChiKey
ZOVJKPRFQDXYEX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    46.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-amino-4-piperidino-benzophenone3-叔丁基-1-甲基-1H-吡唑-5-羰酰氯吡啶 作用下, 以 二氯甲烷 为溶剂, 以86%的产率得到N-(5-benzoyl-2-piperidin-1-ylphenyl)-5-tert-butyl-2-methylpyrazole-3-carboxamide
    参考文献:
    名称:
    Utility of Complementary Molecular Reactivity and Molecular Recognition (CMR/R) Technology and Polymer-Supported Reagents in the Solution-Phase Synthesis of Heterocyclic Carboxamides
    摘要:
    The use of our recently reported chemical library purification strategy in the development of a herbicidal lead, N-(3-benzoylphenyl)-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide (3), is described. The approach applying fundamental properties of complementary molecular reactivity and molecular recognition (CMR/R) as the basis for a general purification strategy was utilized. Polymeric reagents were used in the synthesis to generate reactive species involved in product formation, and complementary molecular reactivity/molecular recognition polymer 8 (CMR/R polymer 8) was used in the solution-phase syntheses of building blocks, primary libraries, and lead refinement libraries. An extension of the CMR/R methodology was applied, utilizing a sequestration enabling reagent (SER), transforming a reactant into an electrophilic species sequestrable by CMR/R polymer 8. This library purification strategy enabled rapid lead generation and lead refinement to afford herbicide 27o. The CMR/R solid-phase purification technique enabled a simple, general, and powerful protocol, eliminating the usual tedious and time-consuming methods required for solution-phase product purification. The result was the synthesis of hundreds of compounds, prepared in a relatively short time, leading to a compound with a 4-fold improvement in herbicidal activity over the initial lead.
    DOI:
    10.1021/jo970571i
  • 作为产物:
    参考文献:
    名称:
    Utility of Complementary Molecular Reactivity and Molecular Recognition (CMR/R) Technology and Polymer-Supported Reagents in the Solution-Phase Synthesis of Heterocyclic Carboxamides
    摘要:
    The use of our recently reported chemical library purification strategy in the development of a herbicidal lead, N-(3-benzoylphenyl)-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide (3), is described. The approach applying fundamental properties of complementary molecular reactivity and molecular recognition (CMR/R) as the basis for a general purification strategy was utilized. Polymeric reagents were used in the synthesis to generate reactive species involved in product formation, and complementary molecular reactivity/molecular recognition polymer 8 (CMR/R polymer 8) was used in the solution-phase syntheses of building blocks, primary libraries, and lead refinement libraries. An extension of the CMR/R methodology was applied, utilizing a sequestration enabling reagent (SER), transforming a reactant into an electrophilic species sequestrable by CMR/R polymer 8. This library purification strategy enabled rapid lead generation and lead refinement to afford herbicide 27o. The CMR/R solid-phase purification technique enabled a simple, general, and powerful protocol, eliminating the usual tedious and time-consuming methods required for solution-phase product purification. The result was the synthesis of hundreds of compounds, prepared in a relatively short time, leading to a compound with a 4-fold improvement in herbicidal activity over the initial lead.
    DOI:
    10.1021/jo970571i
点击查看最新优质反应信息

文献信息

  • Diamine-benzophenones and a process for the preparation thereof
    申请人:Richter Gedeon Vegyeszeti Gyar Rt.
    公开号:US03989701A1
    公开(公告)日:1976-11-02
    New compounds of the general formula (I) ##SPC1## wherein R.sub.1 and R.sub.2 each is a saturated or unsaturated, straight-chained or branched alkyl group, an aralkyl group, a saturated or unsaturated cycloalkyl group or an aryl group, or R.sub.1 and R.sub.2 together with the adjacent nitrogen atom may form substituted or unsubstituted heterocyclic group with or without a further oxygen or nitrogen heteroatom, and R.sub.3 is hydrogen or an acyl group derived from a C.sub.1.sub.-18 carboxylic acid. The compounds are prepared by reducing the corresponding nitro compounds of the general formula (II) ##SPC2## and optionally acylating the obtained product. The compounds of the general formula (I) and their acid addition salts and quaternary ammonium salts are active primarily in the induction of liver microsomal enzyme, but they also possess valuable antipyretic activity and a yohimbine lethality increasing effect characteristic of antidepressants.
    通式(I)的新化合物:##SPC1##其中,R.sub.1和R.sub.2分别是饱和或不饱和的直链或支链烷基,芳基烷基,饱和或不饱和的环烷基或芳基,或R.sub.1和R.sub.2与相邻的氮原子一起形成带有或不带有进一步的氧或氮杂原子的取代或未取代的杂环基;R.sub.3是氢或来源于C.sub.1.sub.-18羧酸的酰基。该化合物的制备方法是还原通式(II)的相应硝基化合物:##SPC2##并可选择性地酰化所得的产物。通式(I)的化合物及其酸加合物和季铵盐主要在诱导肝微粒体酶方面具有活性,但它们还具有有价值的退烧活性和与抗抑郁药物相似的麻醉药物致死率增加效应。
  • Dérivés de benzoyl-phényl-pipéridine, procédé de préparation et application en thérapeutique
    申请人:SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I.
    公开号:EP0069012A1
    公开(公告)日:1983-01-05
    La présente invention concerne de nouveaux dérivés de benzoyl-phényl-pipéridine choisis parmi l'ensemble constitué par: (i) les 2-pipéridinobenzophénones de formule: dans laquelle: - R1, R2 et R3, identiques ou différents, représentent chacun l'atome d'hydrogène, un groupe hydroxy, CF3, un halogène, un groupe alkyle inférieur ou un groupe alkoxy inférieur; -R4 représente l'atome d'hydrogène, un halogène, un groupe N02, un groupe NR'R" [où R' et R", identiques ou différents, représentent l'atome d'hydrogène, un groupe alkyle inférieur ou un groupe C02R (où R représente un groupe alkyle inférieur ou un groupe benzyle)]; - R5 et Rs, identiques ou différents, représentent chacun l'atome d'hydrogène, un groupe alkyle en C1-C4, un groupe OH, un groupe phényle ou un groupe benzyle; et (ii) leurs sels d'addition d'acide. L'invention concerne également le procédé de préparation de ces nouveaux dérivés et leur utilisation en thérapeutique, notamment en tant qu'agents immunostimulants et immunoadjuvants.
    本发明涉及选自以下组别的新苯甲酰-苯基-哌啶衍生物: (i) 式中的 2-哌啶基二苯甲酮: 其中 - R1、R2和R3可以相同或不同,各自代表氢原子、羟基、CF3基团、卤素、低级烷基或低级烷氧基; -R4代表氢原子、卤素、N02基团或NR'R "基团[其中R'和R "可以相同或不同,分别代表氢原子、低级烷基或C02R基团(其中R代表低级烷基或苄基)]; - R5 和 Rs(可以相同或不同)分别代表氢原子、C1-C4 烷基、OH 基、苯基或苄基;以及 (ii) 它们的酸加成盐。 本发明还涉及这些新衍生物的制备过程及其在治疗中的应用,特别是作为免疫刺激剂和免疫佐剂。
  • US3989701A
    申请人:——
    公开号:US3989701A
    公开(公告)日:1976-11-02
  • US4528294A
    申请人:——
    公开号:US4528294A
    公开(公告)日:1985-07-09
  • US4680402A
    申请人:——
    公开号:US4680402A
    公开(公告)日:1987-07-14
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐